DVA
DaVita Inc. · NYSE
- Sector Health Services
- Industry Medical/Nursing Services
- Website davita.com
- Employees(FY) 70000
- ISIN US23918K1088
Performance
-1.33%
1W
-3.27%
1M
-6.92%
3M
+6.78%
6M
+44.95%
YTD
+46.19%
1Y
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Technical Analysis of DVA 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-21 02:30
DaVita Stock Sees Improved Relative Strength Rating(Yahoo Finance)
- 2024-12-19 07:42
- 2024-12-18 18:00
- 2024-12-17 20:34
Analyst Report: DaVita Inc.(Morningstar Research)
- 2024-12-17 19:00
DVA: Lowering target price to $155.00(Argus Research)
- 2024-12-11 05:17
Returns At DaVita (NYSE:DVA) Are On The Way Up(Simply Wall St.)
- 2024-12-10 19:00
DVA: Lowering target price to $162.00(Argus Research)
- 2024-12-03 19:00
DVA: Lowering target price to $172.00(Argus Research)
- 2024-11-26 19:00
DVA: Rating decreased to a HOLD(Argus Research)
- 2024-11-24 19:22
- 2024-11-24 08:22
- 2024-11-20 11:51
When Should You Buy DaVita Inc. (NYSE:DVA)?(Simply Wall St.)
- 2024-11-15 19:08
Analyst Report: DaVita Inc.(Morningstar Research)
- 2024-11-15 04:14
- 2024-11-12 20:05
- 2024-11-12 19:00
DVA: Rating increased to a BUY(Argus Research)
- 2024-11-12 09:05
- 2024-11-12 00:58
Q3 2024 Nuwellis Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-08 16:33
- 2024-11-08 03:33
- 2024-11-06 06:28
- 2024-11-05 19:00
DVA: Lowering target price to $154.00(Argus Research)
- 2024-10-31 19:12
Analyst Report: DaVita Inc.(Morningstar Research)
- 2024-10-31 11:19
- 2024-10-31 06:17
DaVita Third Quarter 2024 Earnings: EPS Misses Expectations(Simply Wall St.)
- 2024-10-31 01:26
Analyst Report: DaVita Inc.(Morningstar Research)
- 2024-10-30 18:38
Why DaVita Stock Withered on Wednesday(Motley Fool)
- 2024-10-30 11:46
- 2024-10-30 11:45
- 2024-10-30 10:05
Q3 2024 DaVita Inc Earnings Call(Thomson Reuters StreetEvents)
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.